Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.

Saleh DaherNamma Lev CohenMuhammad MassarwaMahmud MahamidMira NasserWadi HazouRani OrenRifaat SafadiTawfik Khoury

Published in: PloS one (2018)

PL predicts severity of NAFLD. Its presence may serve as a novel radiological marker for NAFLD/NASH differentiation and disease progression.

Keyphrases